These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34098104)

  • 21. TLR1/2 and 5 induce elevated cytokine levels from rheumatoid arthritis monocytes independent of ACPA or RF autoantibody status.
    Thwaites RS; Unterberger S; Chamberlain G; Walker-Bone K; Davies KA; Sacre S
    Rheumatology (Oxford); 2020 Nov; 59(11):3533-3539. PubMed ID: 32594150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between seropositivity and discontinuation of tumor necrosis factor inhibitors due to ineffectiveness in rheumatoid arthritis.
    Ogawa Y; Takahashi N; Kaneko A; Hirano Y; Kanayama Y; Yabe Y; Oguchi T; Fujibayashi T; Takagi H; Hanabayashi M; Funahashi K; Hayashi M; Tsuboi S; Asai S; Asai N; Matsumoto T; Sobue Y; Ishiguro N; Kojima T
    Clin Rheumatol; 2019 Oct; 38(10):2757-2763. PubMed ID: 31179526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis.
    Sieghart D; Platzer A; Studenic P; Alasti F; Grundhuber M; Swiniarski S; Horn T; Haslacher H; Blüml S; Smolen J; Steiner G
    Front Immunol; 2018; 9():876. PubMed ID: 29740454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of rituximab in resistant palindromic rheumatism: first report in literature.
    Raghavan P; Sreenath S; Cherian S; Shenoy PD
    Clin Rheumatol; 2019 Sep; 38(9):2399-2402. PubMed ID: 31076945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different properties of ACPA and IgM-RF derived from a large dataset: further evidence of two distinct autoantibody systems.
    Ursum J; Bos WH; van de Stadt RJ; Dijkmans BA; van Schaardenburg D
    Arthritis Res Ther; 2009; 11(3):R75. PubMed ID: 19460147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naïve patients classified according to the 2010 ACR/EULAR criteria.
    Nordberg LB; Lillegraven S; Lie E; Aga AB; Olsen IC; Hammer HB; Uhlig T; Jonsson MK; van der Heijde D; Kvien TK; Haavardsholm EA;
    Ann Rheum Dis; 2017 Feb; 76(2):341-345. PubMed ID: 27094444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial Mediterranean fever phenotype progression into anti-cyclic citrullinated peptide antibody-positive rheumatoid arthritis:a case report.
    Yago T; Asano T; Fujita Y; Migita K
    Fukushima J Med Sci; 2020 Dec; 66(3):160-166. PubMed ID: 33162488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two elderly cases of familial mediterranean fever with rheumatoid arthritis.
    Matsuoka N; Iwanaga J; Ichinose Y; Fujiyama K; Tsuboi M; Kawakami A; Migita K
    Int J Rheum Dis; 2018 Oct; 21(10):1873-1877. PubMed ID: 24661635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of palindromic rheumatism: A systematic review.
    Kavandi H; Hashemi SZ; Khalesi E; Khabbazi A
    Int J Clin Pract; 2021 Nov; 75(11):e14868. PubMed ID: 34525234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Palindromic rheumatism with positive anticitrullinated peptide/protein antibodies is not synonymous with rheumatoid arthritis. A longterm followup study.
    Sanmartí R; Cabrera-Villalba S; Gómez-Puerta JA; Ruiz-Esquide V; Hernández MV; Salvador G; Ramirez J; Viñas O; Cañete JD
    J Rheumatol; 2012 Oct; 39(10):1929-33. PubMed ID: 22859345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levels of anti-citrullinated protein antibodies and IgM rheumatoid factor are not associated with outcome in early arthritis patients: a cohort study.
    Ursum J; Bos WH; van Dillen N; Dijkmans BA; van Schaardenburg D
    Arthritis Res Ther; 2010; 12(1):R8. PubMed ID: 20064278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is there subclinical synovitis in patients with palindromic rheumatism in the intercritical period? a clinical and ultrasonographic study according to anticitrullinated protein antibody status.
    Cabrera-Villalba S; Ramirez J; Salvador G; Ruiz-Esquide V; Hernández MV; Inciarte-Mundo J; Gómez-Puerta JA; Cañete JD; Sanmarti R
    J Rheumatol; 2014 Aug; 41(8):1650-5. PubMed ID: 25028368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longterm effects of rituximab on B cell counts and autoantibody production in rheumatoid arthritis: use of high-sensitivity flow cytometry for more sensitive assessment of B cell depletion.
    Váncsa A; Szabó Z; Szamosi S; Bodnár N; Végh E; Gergely L; Szucs G; Szántó S; Szekanecz Z
    J Rheumatol; 2013 May; 40(5):565-71. PubMed ID: 23547216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity.
    Schwedler C; Häupl T; Kalus U; Blanchard V; Burmester GR; Poddubnyy D; Hoppe B
    Arthritis Res Ther; 2018 Mar; 20(1):44. PubMed ID: 29540200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR/EULAR classification of rheumatoid arthritis.
    Van Hoovels L; Jacobs J; Vander Cruyssen B; Van den Bremt S; Verschueren P; Bossuyt X
    Ann Rheum Dis; 2018 May; 77(5):667-677. PubMed ID: 29363510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcome of patients with palindromic rheumatism treated with methotrexate.
    Ghassembaglou A; Esalatmanesh K; Gadakchi L; Nourmohammadi F; Khabbazi A
    Int J Rheum Dis; 2022 Apr; 25(4):489-495. PubMed ID: 35133068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis.
    Bugatti S; Bogliolo L; Vitolo B; Manzo A; Montecucco C; Caporali R
    Arthritis Res Ther; 2016 Oct; 18(1):226. PubMed ID: 27716332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies against cyclic citrullinated peptide don't decrease after 6 months of infliximab treatment in refractory rheumatoid arthritis.
    Kolarz B; Majdan M; Dryglewska M; Darmochwal-Kolarz D
    Rheumatol Int; 2011 Nov; 31(11):1439-43. PubMed ID: 20473501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibody profiling in patients with very early rheumatoid arthritis: a follow-up study.
    Nell-Duxneuner V; Machold K; Stamm T; Eberl G; Heinzl H; Hoefler E; Smolen JS; Steiner G
    Ann Rheum Dis; 2010 Jan; 69(1):169-74. PubMed ID: 19153104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 2010 ACR/EULAR criteria are not sufficiently accurate in the early identification of autoantibody-negative rheumatoid arthritis: Results from the Leiden-EAC and ESPOIR cohorts.
    Boeters DM; Gaujoux-Viala C; Constantin A; van der Helm-van Mil AHM
    Semin Arthritis Rheum; 2017 Oct; 47(2):170-174. PubMed ID: 28601249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.